Position in FATE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$6,571,740
+$6,059,576 QoQ
Shares Held
2,433,978
+365.7% QoQ
Ownership
2.03%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#10
of 156 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FATE Over Time
Shares Held
Position Value (USD)
Derivatives in FATE
reported options exposure · as of Sep 30, 2024CallValue
$175,000
CallShares
50,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026MILLENNIUM MANAGEMENT LLC holds $4,631,421,099 across 322 Biotechnology names. FATE ranks #148 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
468,410 | $232,673,299 | |
| 2 | INSM |
INSMED Inc
|
2,048,005 | $218,358,293 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
1,491,404 | $197,954,052 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
763,880 | $184,072,163 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
543,323 | $154,830,755 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
556,088 | $136,113,659 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
2,071,816 | $118,549,311 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
165,120 | $102,958,924 |
All Filings in FATE
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,571,740 | 2,433,978 | Shares | Sole | 2026-08-14 | |
| 2025-12-31 | $512,164 | 522,617 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,214,477 | 963,871 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $985,250 | 879,688 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $248,752 | 314,877 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $681,766 | 413,192 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $175,000 | 50,000 | Call | Sole | 2024-11-14 | |
| 2024-09-30 | $947,156 | 270,616 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,465,071 | 446,668 | Shares | Sole | 2024-08-14 | |
| 2023-12-31 | $3,342,243 | 893,648 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $4,376,184 | 2,064,238 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,975,290 | 625,061 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $9,878,025 | 1,732,987 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $28,902,562 | 2,864,476 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $14,358,624 | 640,724 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $18,083,725 | 729,771 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $12,024,282 | 310,144 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,180,556 | 20,177 | Shares | Sole | 2022-02-14 | |
| 2021-12-31 | $585,100 | 10,000 | Call | Sole | 2022-02-14 | |
| 2021-09-30 | $6,730,760 | 113,561 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $14,540,275 | 167,534 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $21,270,286 | 257,978 | Shares | Sole | 2021-05-17 | |
| 2021-03-31 | $824,500 | 10,000 | Call | Sole | 2021-05-17 | |
| 2020-12-31 | $28,183,844 | 309,951 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $18,543,921 | 463,946 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $39,121,462 | 1,140,235 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $17,746,567 | 799,035 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||